You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hydroxy-ethyl starch

Showing 1 - 25 of 685
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Valve Diseases Trial in Tehran (Six percent hydroxy ethyl starch 130/0.4, Ringer lactate)

Completed
  • Heart Valve Diseases
  • Six percent hydroxy ethyl starch 130/0.4
  • Ringer lactate
  • Tehran, Iran, Islamic Republic of
    Rajaie CMRC
Jan 23, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

Completed
Has Results
  • Estrogen Receptor Negative
  • +4 more
  • Duarte, California
  • +2 more
Jun 6, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Radical Cystectomy Trial in Mansoura (stroke volume optimization)

Completed
  • Radical Cystectomy
  • stroke volume optimization
  • Mansoura, El-Dakahlia, Egypt
    Urology and nephrology center
Dec 20, 2020

Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous

Recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 6, 2022

Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • Birmingham, Alabama
  • +11 more
May 6, 2022

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +26 more
  • Tampa, Florida
  • +3 more
Jun 22, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Anakinra
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid

Recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Greeley, Colorado
  • +17 more
Jun 13, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )

Terminated
Has Results
  • Gastrinoma
  • +6 more
  • Boston, Massachusetts
    Ecog-Acrin
Dec 1, 2020

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in San Francisco (Everolimus, Archival Tissue

Completed
Has Results
  • Adult Diffuse Astrocytoma
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jul 24, 2020

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

Completed
Has Results
  • Ovarian Endometrioid Adenocarcinoma
  • +8 more
  • Jacksonville, Florida
  • +1 more
Sep 28, 2020

Aerobic Endurance, Metabolism Trial in Natick (High-amylose maize starch+acetate/butyrate, Low-amylose maize starch)

Recruiting
  • Aerobic Endurance
  • Metabolism
  • High-amylose maize starch+acetate/butyrate
  • Low-amylose maize starch
  • Natick, Massachusetts
    United States Army Research Institute of Environmental Medicine
Sep 19, 2023